BioAffinity Technologies Inc (NASDAQ:BIAF) price on current trading day, fall -1.95% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $0.29.
A look at the stock’s price movement, the close in the last trading session was $0.29, moving within a range at $0.2505 and $0.3192. The beta value (5-Year monthly) was 3.137. Turning to its 52-week performance, $3.16 and $0.26 were the 52-week high and 52-week low respectively. Overall, BIAF moved -63.55% over the past month.
BioAffinity Technologies Inc’s market cap currently stands at around $4.46 million, with investors looking forward to this quarter’s earnings report slated for on 2024-Nov-13.
Analysts have a consensus estimate of 2.42M for the company’s revenue for the quarter, with a low and high estimate of 2.42M and 2.42M respectively.
Turning to the stock’s technical picture we see that short term indicators suggest on average that BIAF is a 100% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
BIAF’s current price about -38.15% and -56.02% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 27.01, while 7-day volatility ratio is 25.45% and 22.12% in the 30-day chart. Further, BioAffinity Technologies Inc (BIAF) has a beta value of 3.37, and an average true range (ATR) of 0.08.
If we refocus on BioAffinity Technologies Inc (NASDAQ:BIAF), historical trading data shows that trading volumes averaged 0.59 over the past 10 days and 221.86K over the past 3 months. The company’s latest data on shares outstanding shows there are 13.42 million shares.
The 39.53% of BioAffinity Technologies Inc’s shares are in the hands of company insiders while institutional holders own 3.44% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 0.12 million on 2025-02-28, giving us a short ratio of 1.3. The data shows that as of 2025-02-28 short interest in BioAffinity Technologies Inc (BIAF) stood at 95.0 of shares outstanding, with shares short falling to 0.4 million registered in 2025-01-31. Current price change has pushed the stock -68.52% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the BIAF stock continues to rise going into the next quarter.
